Media Summary: Pascal Touchon, President & CEO, Atara Biotherapeutics, San Francisco, CA, provides an overview of Jan Janisch-Hanzlik had been having strange symptoms for several years, however, it was a sensation that started in her toes and ... Doris Hansen, MD, Moffitt Cancer Center, Tampa, FL, provides insight into the current role of
The Allogeneic Pivot Reshaping The Car T Market Landscape - Detailed Analysis & Overview
Pascal Touchon, President & CEO, Atara Biotherapeutics, San Francisco, CA, provides an overview of Jan Janisch-Hanzlik had been having strange symptoms for several years, however, it was a sensation that started in her toes and ... Doris Hansen, MD, Moffitt Cancer Center, Tampa, FL, provides insight into the current role of Tuna Mutis, MD, PhD, Amsterdam University Medical Center, Amsterdam, The Netherlands, discusses the advantages of using ... "Nothing can prepare you to hear the words, “You have cancer”. At just 27 years old, that was Donato Bernardo's reality. He went ... Currently approved chimeric antigen receptor (
In this dynamic panel from the 2023 CGT Summit hosted by Charles River Laboratories, experts from Charles River, Vernal ... Sattva Neelapu, MD, University of Texas MD Anderson Cancer Center, Houston, TX, evaluates the safety and efficacy of ... Those are big challenges for patients going through CTI um I mean essentially to to explain it uh you have a Julio Delgado, MD, PhD, from the Clinical and Provincial Hospital of Barcelona, Spain, discusses the use of In this video, Dr. Celeste Bello from the Moffitt Cancer Center, breaks down the misconception of Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having "off-the-shelf" ...
